Visufarma

Executive Summary

Visufarma is a Netherlands-based ophthalmic company dedicated to developing and commercializing a comprehensive portfolio of high-quality products for eye health. Founded in 2008, the company addresses a wide range of conditions including dry eye disease, glaucoma, ocular allergy, blepharitis, and retinal health through small molecule therapeutics, medical devices, and nutritional supplements. By focusing on both prescription and over-the-counter solutions, Visufarma aims to provide accessible, effective treatments for patients across Europe and beyond. Operating as a pan-European commercial organization, Visufarma has established a distribution network spanning over 20 countries, with a growing presence in additional international markets. The company's strategy centers on leveraging its existing product portfolio while pursuing pipeline innovation through internal development and strategic partnerships. With a strong commercial foundation and a dedicated focus on ophthalmology, Visufarma is well-positioned to capture market share in the expanding eye care sector. Its private ownership allows for agile decision-making and long-term investment in product development and geographic expansion.

Upcoming Catalysts (preview)

• H2 2026Launch of novel dry eye formulation65% success
• 2027Expansion into Asia-Pacific markets via licensing deal70% success
• Q1 2027Regulatory approval for glaucoma combination therapy55% success